BGOG-ov-19

Randomized, Double-Blind, Phase III Trial of Olaparib vs. Placebo in Patients with Advanced FIGO Stage IIIB – IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer treated with standard First-Line Treatment, Combining Platinum-Taxane Chemotherapy and Bevacizumab Concurrent with Chemotherapy and in Maintenance.

 

Study sites

  • CHR Citadelle, Liège
  • Clinique et maternité St. Elizabeth, Namur
  • Cliniques universitaires de Mont-Godinne, Yvoir
  • Institut Jules Bordet, Bruxelles
  • UZ Antwerpen, Edegem
  • UZ Leuven, Leuven
 

Professional Area

Unlock